COVID-19: FDA Expands Overseas Inspections Freeze Through April

Industry experts advise companies to prepare for paper-based inspection in light of the US FDA's suspended overseas inspections in response to the COVID-19 crisis.

MT2002_Coronavirus Map_1627847941_1200.jpg

The US Food and Drug Administration has postponed most overseas inspections through April citing federal travel restrictions. One industry expert advises companies to prepare strong documentation in case the FDA begins to remotely conduct paper-based inspections.

On 13 March, the coronavirus crisis reached a new level where President Trump declared it a national emergency allowing national,...

More from Regulation

More from Policy & Regulation